As an advisor, I have helped industry-leading companies on corporate finance
issues, R&D
portfolio management, intellectual property strategy, and
technology licensing. Brian has
worked with both private and public companies
at all stages of growth, including Aviron,
COR Therapeutics, Genentech, Genencor,
Hewlett-Packard, Maxygen, MDS, SRI, Watson
Pharmaceuticals and more than 50
other technology leaders. |
 |
 |
 |
||
| Aviron (acquired by MedImmune) | Bios Group LP (acquired by Nutech) | Caliper Lifescience | ||
 |
 |
 |
||
| Cisco Systems | Cor (acquired by Millenium) | Darpa | ||
 |
 |
 |
||
| Ernst & Young | Exploratorium | GBN (acquired by Monitor) | ||
 |
 |
 |
||
| Genencor (acquired by Danisco) | Genentech | Hewlett Packard | ||
 |
 |
 |
||
| Maxygen | MDS |
Millenium (acquired by Takeda) | ||
 |
 |
 |
||
| Sandia Labs | SRI International | Symyx | ||
 |
 |
|||
| Watson Pharmaceuticals | Xenogen (acquired by Caliper) |